Q BIOMED INC.: 10-Q filed 2016-10-17
What Q BIOMED INC. reported in its quarterly report filed 2016-10-17 (fiscal Q3 2016): 19 published measures, 45 facts as tagged in accession 0001424884-16-000254.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-10-17
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001424884-16-000254 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Q BIOMED INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 147,986 | USD | |
| At 2015-11-30 | 131,408 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 1,754,605 | USD | |
| At 2015-11-30 | 387,313 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | -1,606,619 | USD | |
| At 2015-11-30 | -255,905 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 137,986 | USD | |
| At 2015-11-30 | 131,408 | USD | |
| At 2015-08-31 | 100 | USD | |
| At 2014-11-30 | 12,649 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-02 to 2016-08-31 | -1,716,065 | USD | 91 |
| 2015-12-01 to 2016-08-31 | -4,814,174 | USD | 275 |
| 2015-06-02 to 2015-08-31 | -33,202 | USD | 91 |
| 2014-12-01 to 2015-08-31 | -45,184 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-08-31 | -868,497 | USD | 275 |
| 2014-12-01 to 2015-08-31 | -12,700 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-08-31 | 875,075 | USD | 275 |
| 2014-12-01 to 2015-08-31 | 151 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | -5,944,366 | USD | |
| At 2015-11-30 | -1,130,192 | USD |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 147,986 | USD | |
| At 2015-11-30 | 131,408 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-02 to 2016-08-31 | 114,847 | USD | 91 |
| 2015-12-01 to 2016-08-31 | 304,596 | USD | 275 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 1,277,698 | USD | |
| At 2015-11-30 | 91,313 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-08-31 | 50,000 | USD | 275 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-02 to 2016-08-31 | 1,594,186 | USD | 91 |
| 2015-12-01 to 2016-08-31 | 4,301,368 | USD | 275 |
| 2015-06-02 to 2015-08-31 | 33,202 | USD | 91 |
| 2014-12-01 to 2015-08-31 | 45,184 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-02 to 2016-08-31 | 443,222 | USD | 91 |
| 2015-12-01 to 2016-08-31 | 663,500 | USD | 275 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 8,996,753 | shares | |
| At 2015-11-30 | 8,597,131 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-08-31 | 4,328,750 | USD | |
| At 2015-11-30 | 865,690 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-01 to 2016-08-31 | 1,700,000 | USD | 92 |
| 2015-12-01 to 2016-08-31 | 4,800,000 | USD | 275 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-02 to 2016-08-31 | 1,150,964 | USD | 91 |
| 2015-12-01 to 2016-08-31 | 3,637,868 | USD | 275 |
| 2015-06-02 to 2015-08-31 | 33,202 | USD | 91 |
| 2014-12-01 to 2015-08-31 | 45,184 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-01 to 2016-08-31 | 363,593 | USD | 275 |
| 2014-12-01 to 2015-08-31 | 484 | USD | 274 |
Inspect the source
- Entity
- Q BIOMED INC. / CIK 0001596062
- Captured
- SEC response SHA-256
f89c4e51720d8de34ddffc303f833ea01697bd4742662935a9f3cf09e3e7efbc
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001596062.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))